Rocio Rubio
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection.
Journal: Communications medicine
Published: November 19, 2024
Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later.
Journal: The Journal of infection
Published: September 20, 2024
Primary SARS-CoV-2 exposure by vaccination or infection shapes immune responses to omicron variants among a Spanish cohort.
Journal: Nature communications
Published: September 18, 2024
Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic.
Journal: Cell reports
Published: September 09, 2024
High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination.
Journal: Microbes and infection
Published: May 01, 2024
RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers.
Journal: Microbiology spectrum
Published: January 09, 2023
Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile.
Journal: Frontiers in immunology
Published: July 20, 2022
Eleven-month longitudinal study of antibodies in SARS-CoV-2 exposed and naïve primary health care workers upon COVID-19 vaccination.
Journal: Immunology
Published: May 09, 2022
Sustained seropositivity up to 20.5 months after COVID-19.
Journal: BMC medicine
Published: April 19, 2022
Last Updated: 09/26/2026